Thank you to our amazing Respiratory Therapists
23 October 2025
Important notice: Construction and traffic reorganization at the Glen site.
Read more
4 October 2024
As of November 1, 2024, a new medication called nirsevimab will be available in Quebec to prevent respiratory syncytial virus (RSV).
RSV is a common, highly contagious respiratory virus, infecting nearly all children by two years of age.
It is the most common cause of bronchiolitis and pneumonia in children less than one year of age.
A Quebec-based study found RSV was the most common virus (63.6 per cent) in children hospitalized for acute respiratory infection, with higher severity in children born prematurely and babies under six months of age (Papenburg et al, 2012).
Nirsevimab will be available at CLSCs and local points of service for:
How is it given?
Nirsevimab is administered at the start/during RSV season as an intramuscular injection, usually in the thigh muscle.
Where will it be given?
Don’t hesitate to book an appointment for your child!
Thank you to our amazing Respiratory Therapists
23 October 2025
Spiritual Care at The Montreal Children’s Hospital
20 October 2025
A chance at employment for teens with chronic diseases
29 August 2025
Harvest season brings hidden dangers
28 August 2025
Surgery at the MCH: more data to become even better
12 August 2025